CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Nascent Biotech Inc.  (NBIO)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 

Nascent Biotech's ROA per quarter

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

Select the Comparisons : Select the Ratio:                        

Return On Assets (Dec 31 2016)
III. Quarter
(Sep 30 2016)
II. Quarter
(Jun 30 2016)
I. Quarter
(Mar 31 2016)
IV. Quarter
(Dec 31 2015)
III. Quarter
Y / Y Total Assets Change 5.41 % 54.86 % -5 % 137.75 % 176.95 %
Y / Y Net Income Change - - - - -
Return On Assets (TTM) 64 % 81.77 % - - 156.22 %
Total Ranking # 48 # 38 # # # 34
Seq. Total Assets Change -34.86 % 51.17 % -59.93 % 167.16 % -4.3 %
Seq. Net Income Change - - - - -


Roa Comment
Nascent Biotech Inc. yielded Return on Asset in III. Quarter below company average, at 64 %.

ROA decreased compare to previous quarter, due to detoriation of net income.

Within Healthcare sector 12 other companies have achieved higher return on assets. While Return on assets total ranking has deteriorated compare to previous quarter from 38 to 48.

What is ROA?
Return On Assets Company Ranking
Within: No.
Industry # 6
Sector # 13
S&P 500 # 47

Return On Assets Statistics
High Average Low
156.22 %
117.72 %
75.71 %
(Dec. 30, 2015)   (Dec 31 2016)


You need to upgrade your Flash Player
Financial Statements
Nascent Biotech's Equity $ 1 Millions NBIO's Balance sheet
Nascent Biotech's Income $ -1 Millions Quarterly NBIO's Income Statement
NBIO's Income by Division See NBIO's Income by Division

More Return On Equity Ratios
Biotechnology & Drugs Industry Return On Asstes Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
NBIO's Roa Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and overall Market
Highest Ranking Return On Asstes
Lowest Ranking Return On Asstes
Roa for NBIO's Competitors
Roa for Nascent Biotech's Suppliers
Return On Asstes for NBIO's Customers

You may also want to know
NBIO's Roi NBIO's Inventory Turnover Ratio NBIO's Growth Rates NBIO's Dividend Comparisons
NBIO's Annual Roi NBIO's Profitability Ratios NBIO's Asset Turnover Ratio NBIO's Dividend Growth
NBIO's Roe NBIO's Valuation Ratios NBIO's Financial Strength Ratios NBIO's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2016, within Healthcare Sector ROA
Dariohealth Corp.  154.87 %
Ophthalix, Inc.  148.58 %
Elite Pharmaceuticals Inc  148.10 %
Capstone Therapeutics Corp.  146.85 %
Opiant Pharmaceuticals, Inc.  125.86 %
Mannkind Corp  115.31 %
Orgenesis Inc.  109.46 %
Steadymed Ltd.  90.58 %
Tenax Therapeutics, Inc.  81.07 %
Nascent Biotech Inc.  75.71 %
Oculus Innovative Sciences, Inc.  56.90 %
Eagle Pharmaceuticals, Inc.  50.98 %
Five Prime Therapeutics Inc  50.79 %
Masimo Corp  44.81 %
Neurometrix, Inc.  42.40 %
Supernus Pharmaceuticals Inc  36.21 %
Biotelemetry, Inc.  32.92 %
Pro Dex Inc  32.53 %
United Therapeutics Corp  31.76 %
Enzo Biochem Inc  31.09 %
Baxter International Inc  30.71 %
Psychemedics Corp  27.58 %
Gilead Sciences Inc  26.30 %
Titan Pharmaceuticals Inc  25.84 %
Fonar Corporation  24.43 %
Regenerx Biopharmaceuticals Inc  23.95 %
Petmed Express Inc  22.63 %
China Biologic Products, Inc.  21.12 %
Lescarden Inc  20.94 %
Iradimed Corp  20.88 %



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com